Credit Suisse’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Credit Suisse’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,755	Closed	-$1.47M	–	4551
2022 Q2	$1.47M	Buy	+26,755	New	+$1.4M	﹤0.01%	2119
2016 Q2	–	Sell	-371	Closed	-$99K	–	4395
2016 Q1	$99K	Buy	+371	New	+$118K	﹤0.01%	3827
2015 Q4	–	Sell	-580	Closed	-$476K	–	4410
2015 Q3	$476K	Buy	+580	New	+$654K	﹤0.01%	3432

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Credit Suisse's SRRA Position: Q3 2022 in Review

Credit Suisse sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 26,755 shares — an estimated $1.47M sold.

Credit Suisse first reported a position in SRRA in Q3 2015 and held it in 3 quarters. The position peaked at $1.47M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Credit Suisse reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 26,755 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.47M.
Credit Suisse first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
Credit Suisse's Sierra Oncology, Inc. Common Stock position peaked at $1.47M in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.